Dr. Keltner cited research indicating humans have approximately 12 million scent receptors in the nose that help us navigate and interpret the world.
Snapshot · The Mel Robbins Podcast
Dr. Keltner cited research indicating humans have approximately 12 million scent receptors in the nose that help us navigate and interpret the world.
Where this was said
At 1:00:01 · chapter starts 56:42
With a bouquet of flowers set up in the studio — tree peonies, anemones, garden roses, snapdragons, Queen Anne's lace, and lisianthus — Dr. Keltner turns the podcast into a live lab. He guides Mel through a three-stage sensory awe practice. First, vision: she moves her gaze from fine petal details to the full explosion of the bouquet, marveling at the improbability of something so intricate growing from a bulb. Second, scent: one rose transports her to weddings; another to her grandmother's hugs; a lisianthus to cut grass and her father mowing the lawn. Third, touch: the texture of petals returns her to childhood summers in western Michigan, lying in the grass and staring at the sky. Dr. Keltner frames the result beautifully — in just a few minutes, the bouquet became a doorway into Mel's bigger life story, connecting her to parents, husband, grandmother, and self. That's what awe always does: it reveals what was already there.
In a rare live experiment, Dr. Keltner guided Mel Robbins through a multi-sensory awe experience with a bouquet of flowers — sight, smell, touch — triggering memories of her grandmother, father, and husband. This is exactly what awe does: it connects you to your bigger story.
Adding a simple awe-orientation to your regular walk — noticing small and vast details, seeking childlike wonder — reduced physical pain in adults aged 75+ and is linked to greater brain health six years later. You can start today, anywhere, for free.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.